-- Head-to-head clinical results indicate a potential best-in-class combined efficacy & safety prof...
-- Bivalent SCB-1019 significantly boosted RSV-A and RSV-B neutralizing antibody titers in older ad...
-- Bivalent SCB-1019 significantly boosted RSV-A and RSV-B neutralization titers to approximately 6...
--All CIT patients maintained platelet counts >75 x 109/L at 1-week following chemotherapy plus a s...
--First Chinese RSV PreF Vaccine Candidate to Enter Clinical Trial Stage-- SHANGHAI, Dec. 13, 2023 ...
-- Clover's seasonal influenza vaccine BLA submission has been completed in Brazil, boosting Clover...